Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 USD | +0.21% | -3.27% | -7.98% |
Financials (USD)
Sales 2024 * | 1.06M | Sales 2025 * | 170K | Capitalization | 127M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -61M | EV / Sales 2024 * | 12.2 x |
Net cash position 2024 * | 114M | Net cash position 2025 * | 60.6M | EV / Sales 2025 * | 392 x |
P/E ratio 2024 * |
-2.94
x | P/E ratio 2025 * |
-2.4
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.82% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | +0.64% | ||
1 week | -11.40% | ||
Current month | -10.98% | ||
1 month | +15.76% | ||
3 months | -2.08% | ||
6 months | +48.73% | ||
Current year | -8.56% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 23-08-20 |
Joshua Prince
COO | Chief Operating Officer | 54 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
CHM | Chairman | 88 | 00-05-31 |
Jerry Gin
BRD | Director/Board Member | 81 | 16-02-29 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 18 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 4.73 | +0.64% | 53 336 |
24-04-18 | 4.7 | +0.64% | 197,530 |
24-04-17 | 4.67 | +0.43% | 116,230 |
24-04-16 | 4.65 | -2.11% | 180,739 |
24-04-15 | 4.75 | -2.86% | 274,505 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.56% | 127M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.16% | 21.66B | |
-18.35% | 20.77B | |
-8.07% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- VTGN Stock